ORGN · As filed with the SEC
Origin Materials cash flow statement, by fiscal year
The statement as Origin Materials presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED STATEMENTS OF CASH FLOWS · USD thousands
| USD thousands | FY2025 Year ended Dec 31, 2025 | FY2024 Year ended Dec 31, 2024 | FY2023 Year ended Dec 31, 2023 | FY2022 Year ended Dec 31, 2022 | FY2021 Year ended Dec 31, 2021 | FY2020 Year ended Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Cash flows from operating activities | ||||||
| Net loss | (249,698) | (83,697) | 23,798 | 78,569 | 42,090 | (30,302) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
| Depreciation and amortization | 11,175 | 10,715 | 3,363 | 711 | 544 | 479 |
| Amortization on right-of-use asset | — | — | 615 | 582 | 280 | 0 |
| Provision for credit losses | 744 | 1,230 | — | — | — | — |
| Stock-based compensation | 8,914 | 10,080 | 9,400 | 7,235 | 5,767 | 1,630 |
| Amortization of debt issuance costs | — | — | — | 0 | 14 | 90 |
| Accretion of debt discount | — | — | — | 0 | 2,211 | 101 |
| Loss on reserves | 0 | 639 | — | — | — | — |
| Impairment of assets | 195,636 | 15,246 | — | — | — | — |
| Realized loss on marketable securities | 228 | 946 | (1,018) | — | — | — |
| Amortization of premium and discount of marketable securities, net | (139) | (190) | 3,750 | — | — | — |
| Change in fair value of derivative | 15 | (290) | (69) | 443 | 1,326 | 1,088 |
| Change in fair value of common stock warrants liability | (4,399) | 3,225 | (29,531) | (21,988) | — | 0 |
| Change in fair value of preferred stock warrants liability | — | — | — | 0 | 4,525 | 18,498 |
| Change in fair value of earnout liability | (2,462) | 703 | (40,983) | (85,437) | (75,488) | 0 |
| Operating cash flows from operating leases | — | — | — | — | (295) | 0 |
| Change in fair value of convertible notes | (5) | — | — | — | — | — |
| Deferred tax provision | 621 | 640 | (1,246) | — | — | — |
| Other non-cash expenses | 783 | 518 | — | — | — | — |
| Changes in operating assets and liabilities: | ||||||
| Other receivables | — | — | — | (1,734) | (2,563) | 1,007 |
| Grants receivable | — | — | — | 0 | 0 | 87 |
| Accounts receivable net and other receivables | 5,810 | (3,359) | (15,230) | — | — | — |
| Inventory | 182 | 46 | (912) | — | — | — |
| Prepaid expenses and other current assets | (272) | 2,397 | (4,994) | 432 | (3,652) | 53 |
| Other long-term assets | 213 | (4,750) | (12,761) | (5,017) | — | 0 |
| Accounts payable | (1,160) | 373 | 909 | 26 | (395) | 1,203 |
| Accrued expenses | 1,529 | (3,590) | 4,985 | 485 | 3,010 | 349 |
| Related party payable | — | — | — | — | 203 | 256 |
| Payment on operating lease liabilities | — | — | — | (572) | — | 0 |
| Operating lease liabilities | (311) | (350) | (534) | — | — | — |
| Other liabilities, current | (154) | (1,362) | 65 | (329) | 380 | 0 |
| Other liabilities, long-term | (43) | 0 | 38 | 502 | — | 256 |
| Net cash used in operating activities | (32,793) | (50,830) | (60,355) | (26,092) | (22,043) | (5,461) |
| Cash flows from investing activities | ||||||
| License prepayment within other long-term assets | — | 0 | (7,913) | — | — | — |
| Purchases of property, plant, and equipment | (30,207) | (8,953) | (102,188) | (83,691) | (12,268) | (1,786) |
| Proceeds from land held for sale | 2,117 | — | — | — | — | — |
| Proceeds from sale of property, plant, and equipment | 341 | — | — | — | — | — |
| Purchases of marketable securities | (1,067,964) | (1,817,317) | (3,626,305) | (3,823,407) | (2,448,316) | 0 |
| Sales of marketable securities | 1,077,050 | 1,751,508 | 3,605,216 | 3,815,859 | 2,024,089 | 0 |
| Maturities of marketable securities | 17,595 | 103,321 | 157,422 | 180,331 | 25,058 | 0 |
| Capitalized interest on plant construction | — | — | — | (245) | (201) | (268) |
| Capitalized interest on plant construction | — | — | 0 | — | — | — |
| Net cash (used in) provided by investing activities | (1,068) | 28,559 | 26,232 | 88,847 | (411,638) | (2,054) |
| Cash flows from financing activities | ||||||
| Proceeds from stockholders' notes payable, net of debt issuance costs | — | — | — | 0 | 11,707 | 3,166 |
| Payment of notes payable and other liabilities | (6,272) | (4,793) | — | 0 | (906) | 0 |
| Proceeds from convertible notes | 15,000 | — | — | — | — | — |
| Proceeds from Canadian Government Research and Development Program | 1,678 | 8,097 | 0 | 849 | 543 | 2,662 |
| Issuance of common stock | — | — | — | — | 74 | 1 |
| Proceeds from exercise of stock options | 253 | 252 | 146 | 399 | — | 1 |
| Business combination, net of issuance costs paid | — | — | — | 0 | 467,530 | 0 |
| Net cash provided by financing activities | 10,659 | 3,556 | 146 | 1,248 | 478,948 | 5,829 |
| Cash – Beginning | — | — | — | — | 1,123,407 | — |
| Cash – Ending | — | — | — | — | — | 1,123,407 |
| Effects of foreign exchange rate changes on the balance of cash and cash equivalents held in foreign currencies | (182) | (480) | 1,131 | (2,782) | (14) | (52) |
| Net decrease in cash and cash equivalents | (23,384) | (19,195) | (32,846) | 61,221 | 45,253 | (1,738) |
| Cash and cash equivalents beginning of the period | 56,307 | 75,502 | 108,348 | 47,127 | 1,874 | 3,612 |
| Cash and cash equivalents end of the period | 32,923 | 56,307 | 75,502 | 108,348 | 47,127 | 1,874 |
| Supplemental disclosure of cash flow information | ||||||
| Conversion of stockholder convertible notes payable to common stock | — | — | — | 0 | 20,493 | 0 |
| Reclassification of redeemable convertible preferred stock warrants to common stock | — | — | — | 0 | 54,267 | 0 |
| Reclassification of contingently issued equity to liability | — | — | — | 0 | 203,082 | 0 |
| Net assets assumed from business combination | — | — | — | 0 | 81,364 | 0 |
| Debt discount related to derivative liability | — | — | — | 0 | 2,196 | 0 |
| Business combination transaction costs, accrued but not paid | — | — | — | 0 | 609 | 0 |
| Operating lease ROU assets obtained in exchange for lease obligations | — | — | 2,308 | 1,687 | 2,062 | 0 |
| Purchases of fixed assets included in accounts payable and accrued expenses | 3,755 | 1,308 | 1,939 | 17,085 | — | 0 |
| Stock-based compensation capitalized into property, plant, and equipment | — | 0 | 2,236 | 1,894 | — | 0 |
| Accrued interest capitalized into property, plant, and equipment | — | 0 | 367 | — | — | — |
| Purchases of property, plant, and equipment included in notes payable | 7,167 | — | — | — | — | — |
| Cash paid during the year | ||||||
| Income taxes payment | 0 | 23 | 129 | — | — | — |
| Interest payment | 171 | 1,708 | — | — | — | — |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.